H. Carolan

发表

Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy.

Alan Nichol, Karl Otto, Ermias Gete, 2010, International journal of radiation oncology, biology, physics.

Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.

M. Brundage, E. Grunfeld, D. Feldman-Stewart, 2013, Patient education and counseling.

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

A. Mestrovic, N. Chng, S. Tyldesley, 2018, BMC Cancer.

Radiation Oncology Resident and Program Director Perceptions of the Job Market and Impact on Well-being

P. Ingledew, S. Loewen, S. Lefresne, 2020, Cureus.

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.

A. Mestrovic, N. Chng, S. Tyldesley, 2022, JAMA oncology.

Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases

S. Tyldesley, M. Mckenzie, R. Olson, 2011, Supportive Care in Cancer.

Validation of the prognostic utility of ESTRO/EORTC oligometastatic disease classification: a secondary analysis from the population-based phase II SABR-5 trial.

N. Chng, S. Tyldesley, R. Olson, 2022, International journal of radiation oncology, biology, physics.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Do-Hoon Kim, R. Vandermeer, T. Whelan, 2019, The Lancet.

Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia

W. Cheung, D. Ionescu, N. Murray, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Volumetric Radiosurgery for 1 to 10 Brain Metastases: A Multicenter, Single-Arm, Phase 2 Study.

Michael Peacock, Lovedeep Gondara, Alan Nichol, 2016, International journal of radiation oncology, biology, physics.

Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life

G. Iverson, B. Brooks, M. Mckenzie, 2011, Journal of Neuro-Oncology.

A three-isocenter jagged-junction IMRT approach for craniospinal irradiation without beam edge matching for field junctions.

A. Agranovich, Mitchell C C Liu, R. Corns, 2012, International journal of radiation oncology, biology, physics.

The Impact of Peer Review of Volume Delineation in Stereotactic Body Radiation Therapy Planning for Primary Lung Cancer: A Multicenter Quality Assurance Study

Jeffrey Cao, Robert Olson, Eric Berthelet, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Vancouver rapid access clinic for palliative lung radiation, providing more than just rapid access

Mitchell C C Liu, E. Berthelet, M. Mckenzie, 2014, Supportive Care in Cancer.

Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.

M. Brundage, E. Grunfeld, S. Verma, 2013, Breast.

Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?

A. Bezjak, J. Waldron, F. Shepherd, 2005, Lung cancer.

A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ

J. Bottorff, D. Feldman-Stewart, C. Aquino-Parsons, 2017, American journal of clinical oncology.

Re‐irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives

Mitchell C C Liu, N. McVicar, A. Bergman, 2018, Journal of applied clinical medical physics.

Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial.

A. Mestrovic, N. Chng, S. Tyldesley, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predictors of early polymetastatic relapse following stereotactic ablative radiotherapy for up to 5 oligometastases: a secondary analysis of the phase II SABR-5 trial.

N. Chng, S. Tyldesley, Mengxing Liu, 2022, International journal of radiation oncology, biology, physics.

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

A. Mestrovic, N. Chng, S. Tyldesley, 2018, BMC Cancer.

Progression-free survival and local control following stereotactic ablative radiotherapy for up to 5 oligometastases: an analysis from the population-based phase II SABR-5 trial.

N. Chng, S. Tyldesley, Mengxing Liu, 2022, International journal of radiation oncology, biology, physics.